Suchergebnisse - "Capdevila, Jaume"

PubPharm (21)

1

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment : A case report

enthalten in: World journal of hepatology | 2021

von Mirallas, O. | Saoudi, N. | Gómez-Puerto, D. | +9

2

Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2021

von Viúdez, A. | Crespo, G. | Gómez Dorronsoro, M. | +24

3

Genomic profiling of NETs : a comprehensive analysis of the RADIANT trials

enthalten in: Endocrine-related cancer | 2019

von Yao, J. | Garg, A. | Chen, D. | +13

4

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors : The GETNE1003_EVERLAR Study

enthalten in: The oncologist | 2019

von Capdevila, J. | Teulé, A. | Barriuso, J. | +11

5

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors

enthalten in: The oncologist | 2018

von Salazar, R. | Garcia-Carbonero, R. | Libutti, S. | +16

6

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors : Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Yao, J. | Pavel, M. | Lombard-Bohas, C. | +11

CommentIn: J Clin Oncol. 2017 May 1;35(13):1487-1488. - PMID 28113025

7

A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

enthalten in: Anticancer research | 2016

von Fazio, N. | Buzzoni, R. | Baudin, E. | +15

8

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

enthalten in: BMC cancer | 2015

von Capdevila, J. | Sevilla, I. | Alonso, V. | +16

9

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

enthalten in: BMC cancer | 2015

von Capdevila, J. | Sevilla, I. | Alonso, V. | +16

10

Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors : a subgroup analysis of the phase III RADIANT-3 trial

enthalten in: Pancreas | 2015

von Lombard-Bohas, C. | Yao, J. | Hobday, T. | +7